Bimagrumab treatment was associated with a modest, transient rise in LDL-cholesterol, which requires confirmation in larger cardiovascular outcome studies.

Every Sunday: the week’s new conflicts and verdict changes — and nothing else.

Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.